The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Dopamine visualized in the basal ganglia of living man
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ehringer, H., & Hornykiewicz, O. (1960) · Klinische Wochenschrift · doi:10.1007/bf01485901 · Cited by 1,867
Is the mesocortical dopaminergic system involved in Parkinson disease?
Javoy-Agid, F., & Agid, Y. (1980) · Neurology · doi:10.1212/wnl.30.12.1326 · Cited by 413
Behavioral Neurochemistry: Neuroregulators and Behavioral States
Barchas, J. D., Akil, H., Elliott, G. R., Holman, R. B., & Watson, S. J. (1978) · Science · doi:10.1126/science.25486 · Cited by 335
Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood‐brain interface
Hardebo, J. E., & Owman, C. (1980) · Annals of Neurology · doi:10.1002/ana.410080102 · Cited by 267
Anden, N. E., Carlsson, A., & Haggendal, J. (1969) · Annual Review of Pharmacology · doi:10.1146/annurev.pa.09.040169.001003 · Cited by 226
The Carbon-Fluorine Bond in Compounds of Biological Interest
Goldman, P. (1969) · Science · doi:10.1126/science.164.3884.1123 · Cited by 158
MARSDEN, C. D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92797-0 · Cited by 150
The Dopamine Hypothesis: An Overview of Studies With Schizophrenic Patients
Haracz, J. L. (1982) · Schizophrenia Bulletin · doi:10.1093/schbul/8.3.438 · Cited by 129
The enigma of the basal ganglia and movement
MARSDEN, C. D. (1980) · Trends in Neurosciences · doi:10.1016/0166-2236(80)90103-4 · Cited by 107
Cited by
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Motor control and aging: Links to age-related brain structural, functional, and biochemical effects
Seidler, R. D., Bernard, J. A., Burutolu, T. B., Fling, B. W., Gordon, M. T., Gwin, J. T., Kwak, Y., & Lipps, D. B. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.005 · Cited by 1,791
Ametamey, S. M., Honer, M., & Schubiger, P. A. (2008) · Chemical Reviews · doi:10.1021/cr0782426 · Cited by 1,271
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10609 · Cited by 829
Self-citationWong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Frost, J. J., Ravert, H. T., Wilson, A. A., Rosenbaum, A. E., Gjedde, A., Douglass, K. H., et al. (1984) · Science · doi:10.1126/science.6334363 · Cited by 697
Unusual Amino Acids in Medicinal Chemistry
Blaskovich, M. A. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00319 · Cited by 635
Positron Emission Tomography: Human Brain Function and Biochemistry
Phelps, M. E., & Mazziotta, J. C. (1985) · Science · doi:10.1126/science.2860723 · Cited by 469
Clinical Applications of PET in Brain Tumors
Chen, W. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037689 · Cited by 449
Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways
Hilker, R., Thomas, A. V., Klein, J. C., Weisenbach, S., Kalbe, E., Burghaus, L., Jacobs, A. H., Herholz, K., & Heiss, W. D. (2005) · Neurology · doi:10.1212/01.wnl.0000191154.78131.f6 · Cited by 384
Imaging endogenous dopamine competition with [11C]raclopride in the human brain
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379
Leenders, K. L., Salmon, E. P., Tyrrell, P., Perani, D., Brooks, D. J., Sager, H., Jones, T., Marsden, C. D., & Frackowiak, R. S. J. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120034007 · Cited by 376
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
Vingerhoets, F. J. G., Schulzer, M., Calne, D. B., & Snow, B. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410111 · Cited by 359
Leenders, K. L., Palmer, A. J., Quinn, N., Clark, J. C., Firnau, G., Garnett, E. S., Nahmias, C., Jones, T., & Marsden, C. D. (1986) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.8.853 · Cited by 354
Self-citationElevated dopa decarboxylase activity in living brain of patients with psychosis
Reith, J., Benkelfat, C., Sherwin, A., Yasuhara, Y., Kuwabara, H., Andermann, F., Bachneff, S., Cumming, P., Diksic, M., & Dyve, S. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11651 · Cited by 342
Snow, B. J., Tooyama, I., McGeer, E. G., Yamada, T., Calne, D. B., Takahashi, H., & Kimura, H. (1993) · Annals of Neurology · doi:10.1002/ana.410340304 · Cited by 336
In vivo molecular and genomic imaging: new challenges for imaging physics
Cherry, S. R. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/3/r01 · Cited by 334
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging
Frey, K. A., Koeppe, R. A., Kilbourn, M. R., Vander Borght, T. M., Albin, R. L., Gilman, S., & Kuhl, D. E. (1996) · Annals of Neurology · doi:10.1002/ana.410400609 · Cited by 314
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease
Calne, D. B., Langston, J. W., Martin, W. R. W., Stoessl, A. J., Ruth, T. J., Adam, M. J., Pate, B. D., & Schulzer, M. (1985) · Nature · doi:10.1038/317246a0 · Cited by 313
Ramesh, S., & Arachchige, A. S. P. M. (2023) · AIMS Neuroscience · doi:10.3934/neuroscience.2023017 · Cited by 289
Nigrostriatal function in humans studied with positron emission tomography
Martin, W. R. W., Palmer, M. R., Patlak, C. S., & Calne, D. B. (1989) · Annals of Neurology · doi:10.1002/ana.410260407 · Cited by 282
Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., & Brooks, D. J. (1999) · Brain · doi:10.1093/brain/122.9.1637 · Cited by 270
Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine
Becherer, A., Karanikas, G., Szab�, M., Zettinig, G., Asenbaum, S., Marosi, C., Henk, C., Wunderbaldinger, P., Czech, T., Wadsak, W., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1259-1 · Cited by 266
MRI-PET Correlation in Three Dimensions Using a Volume-of-Interest (VOI) Atlas
Evans, A. C., Marrett, S., Torrescorzo, J., Ku, S., & Collins, L. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.40 · Cited by 264
Adams, J. R., van Netten, H., Schulzer, M., Mak, E., Mckenzie, J., Strongosky, A., Sossi, V., Ruth, T. J., Lee, C. S., Farrer, M., et al. (2005) · Brain · doi:10.1093/brain/awh607 · Cited by 262
Positron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson Disease
Bohnen, N. I., Albm, R. L., Koeppe, R. A., Wernette, K. A., Kilbourn, M. R., Minoshima, S., & Frey, K. A. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600276 · Cited by 254
Perani, D., Garibotto, V., Gorini, A., Moresco, R. M., Henin, M., Panzacchi, A., Matarrese, M., Carpinelli, A., Bellodi, L., & Fazio, F. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.233 · Cited by 219
Wearable Sweat Band for Noninvasive Levodopa Monitoring
Tai, L.-C., Liaw, T. S., Lin, Y., Nyein, H. Y. Y., Bariya, M., Ji, W., Hettick, M., Zhao, C., Zhao, J., Hou, L., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02478 · Cited by 177
Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus
Dirkx, M. F., den Ouden, H. E. M., Aarts, E., Timmer, M. H. M., Bloem, B. R., Toni, I., & Helmich, R. C. (2017) · Brain · doi:10.1093/brain/aww331 · Cited by 152
Metadata
- Authors
- Garnett, E. S., Firnau, G., & Nahmias, C.
- Venue
- Nature
- Published
- 1983-09
- Volume
- 305
- Issue
- 5930
- Pages
- 137-138
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2148957121
- Cited by
- 644
- References
- 9
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.